基于SLE-DAS的低疾病活动度状态定义:在多中心真实世界队列中的推导与验证
本研究在真实世界多中心SLE患者队列中,基于SLE疾病活动度评分(SLE-DAS)推导并验证低疾病活动度(LDA)定义。推导队列确定SLE-DAS≤2.48为识别LLDAS的最佳界值,曲线下面积0.965(95%CI 0.935,0.994)。验证队列中该定义对LLDAS的敏感度97.1%、特异度97.7%,Cohen's Kappa=0.933(P<0.001),McNemar检验两种定义无显著差异(P=0.092)。
要点
- 推导队列确定SLE-DAS≤2.48为识别LLDAS的最佳界值,曲线下面积0.965(95%CI 0.935,0.994)。
- 验证队列中SLE-DAS LDA定义对LLDAS的敏感度97.1%、特异度97.7%。
- 两种定义一致性几乎完美(Cohen's Kappa=0.933;P<0.001),McNemar检验无显著差异(P=0.092)。
核心结论
- SLE-DAS LDA是一个经过验证、准确且易于使用的定义,可用于对SLE患者进行低疾病活动度状态分类。
研究设计与样本
- 推导使用葡萄牙单中心SLE队列数据,验证在意大利、法国和西班牙的多中心队列中进行。
- 共纳入774例患者,推导队列300例,验证队列474例。
- 以狼疮低疾病活动度状态(LLDAS)作为对照,采用受试者工作特征曲线分析及bootstrap方法确定SLE-DAS的LDA界值。
- 进一步测试的SLE-DAS LDA定义包括统计学推导的SLE-DAS LDA上限阈值和泼尼松剂量≤7.5 mg/天。
主要发现
- 推导队列中识别LLDAS患者的最佳界值为SLE-DAS≤2.48,曲线下面积0.965(95%CI 0.935,0.994)。
- 在多中心验证队列中,SLE-DAS LDA定义对LLDAS的敏感度为97.1%,特异度为97.7%。
- 两种定义的一致性几乎完美(Cohen's Kappa=0.933;P<0.001)。
- McNemar检验发现两种定义之间无显著差异(P=0.092)。
关键数值与推荐
- SLE-DAS LDA定义:SLE-DAS≤2.48且泼尼松剂量≤7.5 mg/天。
- 推导队列中SLE-DAS≤2.48识别LLDAS的曲线下面积为0.965(95%CI 0.935,0.994)。
- 验证队列中该定义对LLDAS的敏感度97.1%、特异度97.7%,Cohen's Kappa=0.933(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To derive and validate a definition of low disease activity (LDA) for SLE based on the SLE Disease Activity Score (SLE-DAS), in a real-life multicentre cohort of SLE patients. METHODS: Derivation was conducted using data from a monocentric cohort of SLE (Portugal), and validation was performed in a multicentre cohort (Italy, France and Spain). The Lupus Low Disease Activity State (LLDAS) was used as comparator. We applied receiver operating characteristics curve analysis against the LLDAS to determine the cut-off of SLE-DAS for LDA using bootstrap methodology. In a second step, we tested a definition of SLE-DAS LDA that included: (i) the statistically derived SLE-DAS upper threshold for LDA and (ii) prednisone dose ≤7.5 mg/day. In the multicentre validation cohort, we assessed the classification performance of this SLE-DAS LDA definition. RESULTS: We included 774 patients, 300 in the derivation and 474 in the validation cohort. In the derivation cohort, the optimal cut-off to identify patients in LLDAS was SLE-DAS ≤2.48, presenting an area under the curve of 0.965 (95% CI 0.935, 0.994). When applied to the multicentre validation cohort, the SLE-DAS LDA definition showed a sensitivity of 97.1% and a specificity of 97.7% for LLDAS and an almost perfect agreement (Cohen's Kappa = 0.933; P < 0.001). McNemar's test found no significant differences between the two definitions (P = 0.092). CONCLUSION: The SLE-DAS LDA is a validated, accurate and easy-to-use definition for classifying SLE patients in LDA state.
引用
- Assunção H, Jesus D, Larosa M, et al. Definition of low disease activity state based on the SLE-DAS: derivation and validation in a multicentre real-life cohort. Rheumatology (Oxford). 2022. PMID: 34864894. doi:10.1093/rheumatology/keab895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。